SynthesisFrontiers in medicine2026

Efficacy of SGLT2 inhibitors in preventing end-stage kidney disease in patients with IgA nephropathy: a scoping review.

Atthaphong Phongphithakchai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.